메뉴 건너뛰기




Volumn 10, Issue 11 SPEC., 2003, Pages 964-976

Immune responses to adeno-associated virus and its recombinant vectors

Author keywords

Genetic vaccination; Immunogenicity; Recombinant adeno associated virus (rAAV) vectors

Indexed keywords

ADENOVIRUS VECTOR; ALPHA5 INTEGRIN; BASIC FIBROBLAST GROWTH FACTOR; CD4 ANTIGEN; CD40 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOKINE; GREEN FLUORESCENT PROTEIN; IMMUNOSUPPRESSIVE AGENT; LIPOSOME; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; PLASMID DNA; PROTEIN P53; PROTEOHEPARAN SULFATE; RECOMBINANT PROTEIN; TACROLIMUS; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

EID: 0038805301     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302039     Document Type: Review
Times cited : (198)

References (110)
  • 2
    • 0034296244 scopus 로고    scopus 로고
    • Gene therapy vectors based on adeno-associated virus: Characteristics and applications to acquired and inherited diseases
    • Athanasopoulos T, Fabb S, Dickson G. Gene therapy vectors based on adeno-associated virus: characteristics and applications to acquired and inherited diseases. Int J Mol Med 2000; 6: 363-375.
    • (2000) Int. J. Mol. Med. , vol.6 , pp. 363-375
    • Athanasopoulos, T.1    Fabb, S.2    Dickson, G.3
  • 3
    • 0034219436 scopus 로고    scopus 로고
    • Adeno-associated viral vectors as gene delivery vehicles
    • Carter BJ, Samulski RJ. Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 2000; 6: 17-27.
    • (2000) Int. J. Mol. Med. , vol.6 , pp. 17-27
    • Carter, B.J.1    Samulski, R.J.2
  • 4
    • 0035168925 scopus 로고    scopus 로고
    • Hot topics in adeno-associated virus as a gene transfer vector
    • Zhao N, Liu DP, Liang CC. Hot topics in adeno-associated virus as a gene transfer vector. Mol Biotechnol 2001; 19: 229-237.
    • (2001) Mol. Biotechnol. , vol.19 , pp. 229-237
    • Zhao, N.1    Liu, D.P.2    Liang, C.C.3
  • 5
    • 0037765800 scopus 로고    scopus 로고
    • AAV has minimal effects on cellular gene expression compared to other viruses examined using high density microarrays
    • [abstract]
    • Stilwell J, Samulski RJ. AAV has minimal effects on cellular gene expression compared to other viruses examined using high density microarrays [abstract]. Mol Ther 2001; 3: S131.
    • (2001) Mol. Ther. , vol.3
    • Stilwell, J.1    Samulski, R.J.2
  • 6
    • 0032977833 scopus 로고    scopus 로고
    • Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration
    • Brockstedt DG et al. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol 1999; 92: 67-75.
    • (1999) Clin. Immunol. , vol.92 , pp. 67-75
    • Brockstedt, D.G.1
  • 7
    • 0030819372 scopus 로고    scopus 로고
    • Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D
    • Manning WC et al. Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J Virol 1997; 71: 7960-7962.
    • (1997) J. Virol. , vol.71 , pp. 7960-7962
    • Manning, W.C.1
  • 8
    • 0033994625 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
    • Liu D et al. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer. J Virol 2000; 74: 2888-2894.
    • (2000) J. Virol. , vol.74 , pp. 2888-2894
    • Liu, D.1
  • 9
    • 0034921072 scopus 로고    scopus 로고
    • A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
    • Xin KQ et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum Gene Ther 2001; 12: 1047-1061.
    • (2001) Hum. Gene Ther. , vol.12 , pp. 1047-1061
    • Xin, K.Q.1
  • 10
    • 0036147989 scopus 로고    scopus 로고
    • Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells
    • Chiriva-Internati M et al. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells. Eur J Immunol 2002; 32: 30-38.
    • (2002) Eur. J. Immunol. , vol.32 , pp. 30-38
    • Chiriva-Internati, M.1
  • 11
    • 0035207017 scopus 로고    scopus 로고
    • Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adenoassociated virus vector
    • Liu Y et al. Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adenoassociated virus vector. Cancer Gene Ther 2001; 8: 948-957.
    • (2001) Cancer Gene Ther. , vol.8 , pp. 948-957
    • Liu, Y.1
  • 12
    • 0036605994 scopus 로고    scopus 로고
    • Immunogenicity of a p210BCR-ABL fusion domain candidate DNA vaccine targeted to dendritic cells by an rAAV vector in vitro
    • Sun J et al. Immunogenicity of a p210BCR-ABL fusion domain candidate DNA vaccine targeted to dendritic cells by an rAAV vector in vitro. Cancer Res 2002; 62: 3175-3183.
    • (2002) Cancer Res. , vol.62 , pp. 3175-3183
    • Sun, J.1
  • 13
    • 0038103349 scopus 로고    scopus 로고
    • Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy
    • Sun J, Chatterjee S, Wong Jr KK. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy Curr Gene Ther 2002; 2: 485-500.
    • (2002) Curr. Gene Ther. , vol.2 , pp. 485-500
    • Sun, J.1    Chatterjee, S.2    Wong K.K., Jr.3
  • 15
    • 0038442531 scopus 로고    scopus 로고
    • Fields BN, Knipe DM, Howley, PM (eds.). 4th edn, Lippincott, Philadelphia
    • Muzyczka N, Berns KI. (2001) In: Fields BN, Knipe DM, Howley, PM (eds.). Parvoviruses in Virology, 4th edn, Lippincott, Philadelphia, pp 2327-2360.
    • (2001) Parvoviruses in Virology , pp. 2327-2360
    • Muzyczka, N.1    Berns, K.I.2
  • 16
    • 0034608803 scopus 로고    scopus 로고
    • Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model
    • Meyers C et al. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 2002; 272: 338-346.
    • (2002) Virology , vol.272 , pp. 338-346
    • Meyers, C.1
  • 17
    • 0025214094 scopus 로고
    • Site-specific integration by adeno-associated virus
    • Kotin et al. Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 1990; 87: 2211-2215.
    • (1990) Proc. Natl. Acad. Sci. USA , vol.87 , pp. 2211-2215
    • Kotin, A.1
  • 18
    • 0031906147 scopus 로고    scopus 로고
    • Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
    • Summerford C, Samulski RJ. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438-1445.
    • (1998) J. Virol. , vol.72 , pp. 1438-1445
    • Summerford, C.1    Samulski, R.J.2
  • 19
    • 0032589751 scopus 로고    scopus 로고
    • Alpha Vbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
    • Summerford C, Bartlett JS, Samulski RJ. Alpha Vbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med 1999; 5: 78-82.
    • (1999) Nat. Med. , vol.5 , pp. 78-82
    • Summerford, C.1    Bartlett, J.S.2    Samulski, R.J.3
  • 20
    • 0033010884 scopus 로고    scopus 로고
    • Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
    • Qing K et al. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat Med 1999; 5: 71-77.
    • (1999) Nat. Med. , vol.5 , pp. 71-77
    • Qing, K.1
  • 21
    • 0029849257 scopus 로고    scopus 로고
    • Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
    • Dong JY, Fan PD, Frizzell RA. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum Gene Ther 1996; 7: 2101-2112.
    • (1996) Hum. Gene Ther. , vol.7 , pp. 2101-2112
    • Dong, J.Y.1    Fan, P.D.2    Frizzell, R.A.3
  • 22
    • 0033541640 scopus 로고    scopus 로고
    • Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses
    • Clark KR, Liu X, McGrath JP, Johnson PR. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031-1039.
    • (1999) Hum. Gene Ther. , vol.10 , pp. 1031-1039
    • Clark, K.R.1    Liu, X.2    McGrath, J.P.3    Johnson, P.R.4
  • 23
    • 0033022953 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
    • Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973-985.
    • (1999) Gene Therapy , vol.6 , pp. 973-985
    • Zolotukhin, S.1
  • 24
    • 0032853699 scopus 로고    scopus 로고
    • Immune responses to adenovirus and adeno-associated virus in humans
    • Chirmule N et al. Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574-1583.
    • (1999) Gene Therapy , vol.6 , pp. 1574-1583
    • Chirmule, N.1
  • 25
    • 0031969428 scopus 로고    scopus 로고
    • Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
    • Jooss K, Yang Y, Fisher KJ, Wilson JM. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol 1998; 72: 4212-4223.
    • (1998) J. Virol. , vol.72 , pp. 4212-4223
    • Jooss, K.1    Yang, Y.2    Fisher, K.J.3    Wilson, J.M.4
  • 26
    • 0033977047 scopus 로고    scopus 로고
    • Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
    • Chirmule N et al. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol 2000; 74: 2420-2425.
    • (2000) J. Virol. , vol.74 , pp. 2420-2425
    • Chirmule, N.1
  • 27
    • 0032826773 scopus 로고    scopus 로고
    • Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model
    • Hernandez YJ et al. Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model. J Virol 1999; 73: 8549-8558.
    • (1999) J. Virol. , vol.73 , pp. 8549-8558
    • Hernandez, Y.J.1
  • 28
    • 0031743947 scopus 로고    scopus 로고
    • Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure
    • Halbert CL, Standaert TA, Wilson CB, Miller AD. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998; 72: 9795-9805.
    • (1998) J. Virol. , vol.72 , pp. 9795-9805
    • Halbert, C.L.1    Standaert, T.A.2    Wilson, C.B.3    Miller, A.D.4
  • 29
    • 0032031816 scopus 로고    scopus 로고
    • Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors
    • Manning et al. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors. Hum Gene Ther 1998; 9: 477-485.
    • (1998) Hum. Gene Ther. , vol.9 , pp. 477-485
    • Manning, A.1
  • 30
    • 0034169676 scopus 로고    scopus 로고
    • Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors
    • Xiao W et al. Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther 2000; 1: 323-329.
    • (2000) Mol. Ther. , vol.1 , pp. 323-329
    • Xiao, W.1
  • 31
    • 0028790247 scopus 로고
    • The immune response and the eye. TCR-alpha chain related molecules regulate the systemic immunity to antigen presented in the eye
    • Griffith TS et al. The immune response and the eye. TCR-alpha chain related molecules regulate the systemic immunity to antigen presented in the eye. Int Immunol 1995; 7: 1617-1625.
    • (1995) Int. Immunol. , vol.7 , pp. 1617-1625
    • Griffith, T.S.1
  • 32
    • 0034122206 scopus 로고    scopus 로고
    • In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation
    • Kezuka T, Streilein JW. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci 2000; 41: 1803-1811.
    • (2000) Invest. Ophthalmol. Vis. Sci. , vol.41 , pp. 1803-1811
    • Kezuka, T.1    Streilein, J.W.2
  • 33
    • 0036166251 scopus 로고    scopus 로고
    • A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus
    • Anand V et al. A deviant immune response to viral proteins and transgene product is generated on subretinal administration of adenovirus and adeno-associated virus. Mol Ther 2002; 5: 125-132.
    • (2002) Mol. Ther. , vol.5 , pp. 125-132
    • Anand, V.1
  • 34
    • 0014247830 scopus 로고
    • Serologic evidence for human infection with adenovirus-associated viruses
    • Blacklow NR, Hoggan MD, Rowe WP. Serologic evidence for human infection with adenovirus-associated viruses. J Natl Cancer Inst 1968; 40: 319-327.
    • (1968) J. Natl. Cancer Inst. , vol.40 , pp. 319-327
    • Blacklow, N.R.1    Hoggan, M.D.2    Rowe, W.P.3
  • 35
    • 0015144322 scopus 로고
    • A seroepidemiologic study of adenovirus-associated virus infection in infants and children
    • Blacklow NR et al. A seroepidemiologic study of adenovirus-associated virus infection in infants and children. Am J Epidemiol 1971; 94: 359-366.
    • (1971) Am. J. Epidemiol. , vol.94 , pp. 359-366
    • Blacklow, N.R.1
  • 36
    • 0021340974 scopus 로고
    • Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus
    • Georg-Fries B, Biederlack S, Wolf J, zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology 1984; 134: 64-71.
    • (1984) Virology , vol.134 , pp. 64-71
    • Georg-Fries, B.1    Biederlack, S.2    Wolf, J.3    zur Hausen, H.4
  • 37
    • 0345411588 scopus 로고    scopus 로고
    • Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)
    • Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol 1999; 59: 406-411.
    • (1999) J. Med. Virol. , vol.59 , pp. 406-411
    • Erles, K.1    Sebokova, P.2    Schlehofer, J.R.3
  • 38
    • 0030797433 scopus 로고    scopus 로고
    • Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins
    • Hermanns J et al. Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. J Virol 1997; 71: 6020-6027.
    • (1997) J. Virol. , vol.71 , pp. 6020-6027
    • Hermanns, J.1
  • 39
    • 0035974901 scopus 로고    scopus 로고
    • Virus-mediated killing of cells that lack p53 activity
    • Raj K, Ogston P, Beard P. Virus-mediated killing of cells that lack p53 activity. Nature 2001; 412: 914-917.
    • (2001) Nature , vol.412 , pp. 914-917
    • Raj, K.1    Ogston, P.2    Beard, P.3
  • 40
    • 0028281022 scopus 로고
    • The tumor suppressive properties of adeno-associated viruses
    • Schlehofer JR. The tumor suppressive properties of adeno-associated viruses. Mutat Res 1994; 305: 303-313.
    • (1994) Mutat. Res. , vol.305 , pp. 303-313
    • Schlehofer, J.R.1
  • 41
    • 0035229222 scopus 로고    scopus 로고
    • Gene therapy: Recombinant adeno-associated virus vectors
    • Smith-Arica JR, Bartlett JS. Gene therapy: recombinant adeno-associated virus vectors. Curr Cardiol Rep 2001; 3: 43-49.
    • (2001) Curr. Cardiol. Rep. , vol.3 , pp. 43-49
    • Smith-Arica, J.R.1    Bartlett, J.S.2
  • 42
    • 0034897484 scopus 로고    scopus 로고
    • Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma
    • Walz CM et al. Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphoma. J Med Virol 2001; 65: 185-189.
    • (2001) J. Med. Virol. , vol.65 , pp. 185-189
    • Walz, C.M.1
  • 43
    • 0032924185 scopus 로고    scopus 로고
    • Gene therapy vectors based on adeno-associated virus type 1
    • Xiao W et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994-4003.
    • (1999) J. Virol. , vol.73 , pp. 3994-4003
    • Xiao, W.1
  • 44
    • 0033920298 scopus 로고    scopus 로고
    • Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: Implications for gene therapy and virus structure
    • Moskalenko M et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J Virol 2000; 74: 1761-1766.
    • (2000) J. Virol. , vol.74 , pp. 1761-1766
    • Moskalenko, M.1
  • 45
    • 0033960160 scopus 로고    scopus 로고
    • Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes
    • Halbert CL et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000; 74: 1524-1532.
    • (2000) J. Virol. , vol.74 , pp. 1524-1532
    • Halbert, C.L.1
  • 46
    • 0034968125 scopus 로고    scopus 로고
    • Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer
    • Hildinger M et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol 2001; 75: 6199-6203.
    • (2001) J. Virol. , vol.75 , pp. 6199-6203
    • Hildinger, M.1
  • 47
    • 0032853032 scopus 로고    scopus 로고
    • Repeated delivery of adeno-associated virus vectors to the rabbit airway
    • Beck SE et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J Virol 1999; 73: 9446-9455.
    • (1999) J. Virol. , vol.73 , pp. 9446-9455
    • Beck, S.E.1
  • 48
    • 0034628570 scopus 로고    scopus 로고
    • Additional transduction events after subretinal readministration of recombinant adeno-associated virus
    • Anand V et al. Additional transduction events after subretinal readministration of recombinant adeno-associated virus. Hum Gene Ther 2000; 11: 449-57.
    • (2000) Hum. Gene Ther. , vol.11 , pp. 449-457
    • Anand, V.1
  • 49
    • 0031058024 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus for muscle directed gene therapy
    • Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nat Med 1997; 3: 306-312.
    • (1997) Nat. Med. , vol.3 , pp. 306-312
    • Fisher, K.J.1
  • 50
    • 0034050904 scopus 로고    scopus 로고
    • Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
    • Kay MA et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-261.
    • (2000) Nat. Genet. , vol.24 , pp. 257-261
    • Kay, M.A.1
  • 51
    • 0031984786 scopus 로고    scopus 로고
    • Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2
    • Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
    • (1998) J. Virol. , vol.72 , pp. 309-319
    • Rutledge, E.A.1    Halbert, C.L.2    Russell, D.W.3
  • 52
    • 0037015049 scopus 로고    scopus 로고
    • Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
    • Gao GP et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 11854-11859
    • Gao, G.P.1
  • 53
    • 0031894064 scopus 로고    scopus 로고
    • Discrimination between different types of human adeno-associated viruses in clinical samples by PCR
    • Tobiasch E et al. Discrimination between different types of human adeno-associated viruses in clinical samples by PCR. J Virol Methods 1998; 71: 17-25.
    • (1998) J. Virol. Methods , vol.71 , pp. 17-25
    • Tobiasch, E.1
  • 54
    • 0034724209 scopus 로고    scopus 로고
    • Recombinant adeno-associated virus type 2,4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
    • Davidson BL et al. Recombinant adeno-associated virus type 2,4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428-3432.
    • (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 3428-3432
    • Davidson, B.L.1
  • 55
    • 0036140216 scopus 로고    scopus 로고
    • Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
    • Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
    • (2002) J. Virol. , vol.76 , pp. 791-801
    • Rabinowitz, J.E.1
  • 56
    • 0034842912 scopus 로고    scopus 로고
    • Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vector
    • Chao H et al. Sustained and complete phenotype correction of hemophilia B mice following intramuscular injection of AAV1 serotype vector. Mol Ther 2001; 4: 217-222.
    • (2001) Mol. Ther. , vol.4 , pp. 217-222
    • Chao, H.1
  • 57
    • 0028222954 scopus 로고
    • Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes
    • Philip R et al. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol Cell Biol 1994; 14: 2411-2418.
    • (1994) Mol. Cell Biol. , vol.14 , pp. 2411-2418
    • Philip, R.1
  • 58
    • 0031727714 scopus 로고    scopus 로고
    • Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors
    • Fan L et al. Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors. Gene Therapy 1998; 5: 1434-1440.
    • (1998) Gene Therapy , vol.5 , pp. 1434-1440
    • Fan, L.1
  • 59
    • 0029797538 scopus 로고    scopus 로고
    • Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: Efficient promoter activity of AAV sequences and in vivo delivery via liposomes
    • Baudard M et al. Expression of the human multidrug resistance and glucocerebrosidase cDNAs from adeno-associated vectors: efficient promoter activity of AAV sequences and in vivo delivery via liposomes. Hum Gene Ther 1996; 7: 1309-1322.
    • (1996) Hum. Gene Ther. , vol.7 , pp. 1309-1322
    • Baudard, M.1
  • 60
    • 0033370798 scopus 로고    scopus 로고
    • Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension
    • Tang X et al. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension. Am J Physiol 1999; 277: H2392-H2399.
    • (1999) Am. J. Physiol. , vol.277
    • Tang, X.1
  • 61
    • 0028060363 scopus 로고
    • Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors
    • Podsakoff G, Wong Jr KK, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994; 68: 5656-5666.
    • (1994) J. Virol. , vol.68 , pp. 5656-5666
    • Podsakoff, G.1    Wong K.K., Jr.2    Chatterjee, S.3
  • 62
    • 0030914867 scopus 로고    scopus 로고
    • Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment
    • Bradford GB, Williams B, Rossi R, Bertoncello I. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol 1997; 25: 445-453.
    • (1997) Exp. Hematol. , vol.25 , pp. 445-453
    • Bradford, G.B.1    Williams, B.2    Rossi, R.3    Bertoncello, I.4
  • 63
    • 0036493384 scopus 로고    scopus 로고
    • Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients
    • Jetmore A et al. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients. Blood 2002; 99: 1585-1593.
    • (2002) Blood , vol.99 , pp. 1585-1593
    • Jetmore, A.1
  • 64
    • 0029945425 scopus 로고    scopus 로고
    • Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction
    • Fisher-Adams G et al. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 1996; 88: 492-504.
    • (1996) Blood , vol.88 , pp. 492-504
    • Fisher-Adams, G.1
  • 65
    • 0030879933 scopus 로고    scopus 로고
    • Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
    • Ponnazhagan S et al. Adeno-associated virus type 2-mediated transduction in primary human bone marrow-derived CD34+ hematopoietic progenitor cells: donor variation and correlation of transgene expression with cellular differentiation. J Virol 1997; 71: 8262-8267.
    • (1997) J. Virol. , vol.71 , pp. 8262-8267
    • Ponnazhagan, S.1
  • 66
    • 0033559749 scopus 로고    scopus 로고
    • Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors
    • Chatterjee S et al. Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 1999; 93: 1882-1894.
    • (1999) Blood , vol.93 , pp. 1882-1894
    • Chatterjee, S.1
  • 67
    • 0033995253 scopus 로고    scopus 로고
    • Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV
    • Nathwani AC et al. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Therapy 2000; 7: 183-195.
    • (2000) Gene Therapy , vol.7 , pp. 183-195
    • Nathwani, A.C.1
  • 68
    • 0034952156 scopus 로고    scopus 로고
    • Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice
    • Tan M et al. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice. Mol Ther 2001; 3: 940-946.
    • (2001) Mol. Ther. , vol.3 , pp. 940-946
    • Tan, M.1
  • 69
    • 0036149232 scopus 로고    scopus 로고
    • A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells
    • Shayakhmetov DM et al. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J Virol 2002; 76: 1135-1143.
    • (2002) J. Virol. , vol.76 , pp. 1135-1143
    • Shayakhmetov, D.M.1
  • 70
    • 0032870158 scopus 로고    scopus 로고
    • Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2
    • Girod A et al. Genetic capsid modifications allow efficient retargeting of adeno-associated virus type 2. Nat Med 1999; 5: 1052-1056.
    • (1999) Nat. Med. , vol.5 , pp. 1052-1056
    • Girod, A.1
  • 71
    • 0034814413 scopus 로고    scopus 로고
    • Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors
    • Shi W, Arnold GS, Bartlett JS. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum Gene Ther 2001; 12: 1697-1711.
    • (2001) Hum. Gene Ther. , vol.12 , pp. 1697-1711
    • Shi, W.1    Arnold, G.S.2    Bartlett, J.S.3
  • 72
    • 0033808531 scopus 로고    scopus 로고
    • Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: Epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection
    • Wobus CE et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J Virol 2000; 74: 9281-993.
    • (2000) J. Virol. , vol.74 , pp. 9281-9993
    • Wobus, C.E.1
  • 73
    • 0036678455 scopus 로고    scopus 로고
    • The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
    • Xie Q et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 10405-10410.
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 10405-10410
    • Xie, Q.1
  • 74
    • 0030984335 scopus 로고    scopus 로고
    • Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver
    • Kay M et al. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver, Proc Natl Acad Sci USA 1997; 94: 4686-4691.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 4686-4691
    • Kay, M.1
  • 75
    • 0034853102 scopus 로고    scopus 로고
    • Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9
    • Fields PA et al. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9. Mol Ther 2001; 4: 201-210.
    • (2001) Mol. Ther. , vol.4 , pp. 201-210
    • Fields, P.A.1
  • 76
    • 0030902985 scopus 로고    scopus 로고
    • Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
    • Herzog RW et al. Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci USA 1997; 94: 5804-5809.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 5804-5809
    • Herzog, R.W.1
  • 77
    • 17444387438 scopus 로고    scopus 로고
    • Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
    • Herzog RW et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56-63.
    • (1999) Nat. Med. , vol.5 , pp. 56-63
    • Herzog, R.W.1
  • 78
    • 0030997346 scopus 로고    scopus 로고
    • Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
    • Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-276.
    • (1997) Nat. Genet. , vol.16 , pp. 270-276
    • Snyder, R.O.1
  • 79
    • 17444372024 scopus 로고    scopus 로고
    • Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
    • Snyder RO et al. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5: 64-70.
    • (1999) Nat. Med. , vol.5 , pp. 64-70
    • Snyder, R.O.1
  • 80
    • 0034137797 scopus 로고    scopus 로고
    • Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
    • Wang L et al. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Mol Ther 2000; 1: 154-158.
    • (2000) Mol. Ther. , vol.1 , pp. 154-158
    • Wang, L.1
  • 81
    • 0035877984 scopus 로고    scopus 로고
    • Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX
    • Ge Y, Powell S, Van Roey M, McArthur JG. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 2001; 97: 3733-3737.
    • (2001) Blood , vol.97 , pp. 3733-3737
    • Ge, Y.1    Powell, S.2    Van Roey, M.3    McArthur, J.G.4
  • 82
    • 0034849318 scopus 로고    scopus 로고
    • Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation
    • Herzog RW et al. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation. Mol Ther 2001; 4: 192-200.
    • (2001) Mol. Ther. , vol.4 , pp. 192-200
    • Herzog, R.W.1
  • 83
    • 0037089331 scopus 로고    scopus 로고
    • Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
    • Mount JD et al. Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy. Blood 2002; 99: 2670-2676.
    • (2002) Blood , vol.99 , pp. 2670-2676
    • Mount, J.D.1
  • 84
    • 13144305062 scopus 로고    scopus 로고
    • Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
    • Song S et al. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc Natl Acad Sci USA 1998; 95: 14384-14388.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 14384-14388
    • Song, S.1
  • 85
    • 0036227449 scopus 로고    scopus 로고
    • Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
    • Zaiss AK et al. Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors. J Virol 2002; 76: 4580-4590.
    • (2002) J. Virol. , vol.76 , pp. 4580-4590
    • Zaiss, A.K.1
  • 86
    • 0031011987 scopus 로고    scopus 로고
    • Adeno-associated virus 2-mediated gene transfer in vivo: Organ-tropism and expression of transduced sequences in mice
    • Ponnazhagan S et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 1997; 190: 203-210.
    • (1997) Gene , vol.190 , pp. 203-210
    • Ponnazhagan, S.1
  • 87
    • 0029843596 scopus 로고    scopus 로고
    • Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
    • Xiao X, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098-8108.
    • (1996) J. Virol. , vol.70 , pp. 8098-8108
    • Xiao, X.1    Li, J.2    Samulski, R.J.3
  • 88
    • 0034151775 scopus 로고    scopus 로고
    • Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX
    • Fields PA et al. Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol Ther 2000; 1: 225-235.
    • (2000) Mol. Ther. , vol.1 , pp. 225-235
    • Fields, P.A.1
  • 89
    • 0034749458 scopus 로고    scopus 로고
    • Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors
    • Sarukhan A et al. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269-277.
    • (2001) J. Virol. , vol.75 , pp. 269-277
    • Sarukhan, A.1
  • 90
    • 0033882190 scopus 로고    scopus 로고
    • CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: Role of immature dendritic cells
    • Zhang Y, Chirmule N, Gao G, Wilson J. CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells. J Virol 2000; 74: 8003-8010.
    • (2000) J. Virol. , vol.74 , pp. 8003-8010
    • Zhang, Y.1    Chirmule, N.2    Gao, G.3    Wilson, J.4
  • 91
    • 0035346104 scopus 로고    scopus 로고
    • Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors
    • Sarukhan A, Soudais C, Danos O, Jooss K. Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med 2001; 3: 260-270.
    • (2001) J. Gene Med. , vol.3 , pp. 260-270
    • Sarukhan, A.1    Soudais, C.2    Danos, O.3    Jooss, K.4
  • 92
    • 13344261952 scopus 로고    scopus 로고
    • T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients
    • Riddell SR et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat Med 1996; 2: 216-223.
    • (1996) Nat. Med. , vol.2 , pp. 216-223
    • Riddell, S.R.1
  • 93
    • 0034828903 scopus 로고    scopus 로고
    • Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors
    • Song S et al. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2001; 8: 1299-1306.
    • (2001) Gene Therapy , vol.8 , pp. 1299-1306
    • Song, S.1
  • 94
    • 0035956882 scopus 로고    scopus 로고
    • Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice
    • Jung SC et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA 2001; 98: 2676-2681.
    • (2001) Proc. Natl. Acad. Sci. USA , vol.98 , pp. 2676-2681
    • Jung, S.C.1
  • 95
    • 17944388584 scopus 로고    scopus 로고
    • An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy
    • During MJ et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy Science 2000; 287: 1453-1460.
    • (2000) Science , vol.287 , pp. 1453-1460
    • During, M.J.1
  • 96
    • 0035915778 scopus 로고    scopus 로고
    • Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies
    • Cordier L et al. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. Hum Gene Ther 2001; 12: 205-215.
    • (2001) Hum. Gene Ther. , vol.12 , pp. 205-215
    • Cordier, L.1
  • 97
    • 0036892308 scopus 로고    scopus 로고
    • Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product
    • Yuasa K et al. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Therapy 2002; 9: 1576-1588.
    • (2002) Gene Therapy , vol.9 , pp. 1576-1588
    • Yuasa, K.1
  • 98
    • 0033587482 scopus 로고    scopus 로고
    • Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
    • Pastore L et al. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum Gene Ther 1999; 10: 1773-1781.
    • (1999) Hum. Gene Ther. , vol.10 , pp. 1773-1781
    • Pastore, L.1
  • 99
    • 0030915310 scopus 로고    scopus 로고
    • Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
    • Bronte V et al. Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine. Proc Natl Acad Sci USA 1997; 94: 3183-3188.
    • (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 3183-3188
    • Bronte, V.1
  • 100
    • 0031838721 scopus 로고    scopus 로고
    • Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver
    • Nakai H et al. Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 1998; 91: 4600-4607.
    • (1998) Blood , vol.91 , pp. 4600-4607
    • Nakai, H.1
  • 101
    • 0035282898 scopus 로고    scopus 로고
    • Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
    • Nathwani AC et al. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 2001; 97: 1258-1265.
    • (2001) Blood , vol.97 , pp. 1258-1265
    • Nathwani, A.C.1
  • 102
    • 0035937316 scopus 로고    scopus 로고
    • CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice
    • Xu L et al. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 2001; 12: 563-573.
    • (2001) Hum. Gene Ther. , vol.12 , pp. 563-573
    • Xu, L.1
  • 103
    • 0035080378 scopus 로고    scopus 로고
    • Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice
    • Fields PA et al. Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Therapy 2001; 8: 354-361.
    • (2001) Gene Therapy , vol.8 , pp. 354-361
    • Fields, P.A.1
  • 104
    • 0034161486 scopus 로고    scopus 로고
    • Sustained expression of human factor VIII in mice using a parvovirus-based vector
    • Chao H, Mao L, Bruce AT, Walsh CE. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 2000; 95: 1594-1599.
    • (2000) Blood , vol.95 , pp. 1594-1599
    • Chao, H.1    Mao, L.2    Bruce, A.T.3    Walsh, C.E.4
  • 105
    • 0036376642 scopus 로고    scopus 로고
    • Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
    • Herzog RW et al. Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy. Hum Gene Ther 2002; 13: 1281-1291.
    • (2002) Hum. Gene Ther. , vol.13 , pp. 1281-1291
    • Herzog, R.W.1
  • 106
    • 0035874523 scopus 로고    scopus 로고
    • Induction of tolerance to human factor VIII in mice
    • Chao H, Walsh CE. Induction of tolerance to human factor VIII in mice. Blood 2001; 97: 3311-3312.
    • (2001) Blood , vol.97 , pp. 3311-3312
    • Chao, H.1    Walsh, C.E.2
  • 107
    • 0033021870 scopus 로고    scopus 로고
    • In utero gene therapy: The case against
    • Billings PR. In utero gene therapy: the case against. Nat Med 1999; 5: 255-256.
    • (1999) Nat. Med. , vol.5 , pp. 255-256
    • Billings, P.R.1
  • 108
    • 0036371236 scopus 로고    scopus 로고
    • Sustained delivery of therapeutic concentrations of human clotting factor IX - A comparison of adenoviral and AAV vectors administered in utero
    • Schneider H et al. Sustained delivery of therapeutic concentrations of human clotting factor IX - a comparison of adenoviral and AAV vectors administered in utero. J Gene Med 2002; 4: 46-53.
    • (2002) J. Gene Med. , vol.4 , pp. 46-53
    • Schneider, H.1
  • 109
    • 0034981261 scopus 로고    scopus 로고
    • In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression
    • Lipshutz GS et al. In utero delivery of adeno-associated viral vectors: intraperitoneal gene transfer produces long-term expression. Mol Ther 2001; 3: 284-292.
    • (2001) Mol. Ther. , vol.3 , pp. 284-292
    • Lipshutz, G.S.1
  • 110
    • 0036081135 scopus 로고    scopus 로고
    • Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice
    • Jerebtsova M, Batshaw ML, Ye X Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice. Pediatr Res 2002; 52: 95-104.
    • (2002) Pediatr. Res. , vol.52 , pp. 95-104
    • Jerebtsova, M.1    Batshaw, M.L.2    Ye, X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.